Discover 1,972 paid clinical trials in Miramar, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,972
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: Miami FL, West Palm Beach FL, Fort Myers FL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase 3, Recruiting
A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Miami FL, Tampa FL, Jacksonville FL, Atlanta GA,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase 2, Phase 3, Recruiting
A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
for
Lymphoma, Lymphoma, Large B-Cell, Diffuse
Location: Miami FL, Boston MA
Sponsor: Jennifer Crombie, MD
Sex: All
Age: 18+
Code: NCT05800366
Phase 2, Recruiting
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment
Get alerts for new trials in your area by subscribing now
A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma
for
Endometrial Adenocarcinoma
Location: Miami Beach FL, Atlanta GA, New Orleans LA,
Sponsor: Acrivon Therapeutics
Sex: Female
Age: 18+
Code: NCT05548296
Phase 2, Recruiting
Comparing The Safety And Efficacy Of DEFENCATH® In Reducing Central-Line Bloodstream Infections (CLABSIs) In Adults And Adolescent Participants Receiving Total Parenteral Nutrition Through A Central Venous Catheter (CVC)
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Doral FL, Atlanta GA, Nashville TN, Washington D.C. DC,
Sponsor: CorMedix Therapeutics
Sex: All
Age: 12+
Code: NCT06822426
Phase 3, Recruiting
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
for
GIST - Gastrointestinal Stromal Tumor, GIST,
Location: Miami FL, Tampa FL, Jacksonville FL, Chapel Hill NC,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07406633
Phase 2, Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
for
Lymphoma, Non-Hodgkin's, Lymphoma, Diffuse Large B-Cell,
Location: Miami FL, Sarasota FL, Atlanta GA, Nashville TN,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07226843
Phase 1, Recruiting
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
for
Advanced Gastrointestinal Stromal Tumors, Metastatic Cancer
Location: Miami FL, Orlando FL, Tampa FL, Washington D.C. DC,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05208047
Phase 3, Recruiting
A Study of TORL-5-700 in Relapsed/Refractory Non Hodgkin's Lymphoma
for
Histologically Confirmed Relapsed or Refractory B-cell Non-Hodgkin Lymphoma,
Location: Miami FL, Nashville TN, Dallas TX, Iowa City IA,
Sponsor: TORL Biotherapeutics, LLC
Sex: All
Age: 18+
Code: NCT07439653
Phase 1, Phase 2, Recruiting
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
for
Angioimmunoblastic T-cell Lymphoma,
Location: Miami FL, Deerfield Beach FL, Charleston SC, Augusta GA,
A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer
for
Unresectable Melanoma, Metastatic Melanoma,
Location: Miami FL, Orlando FL, Tampa FL, Louisville KY,
Sponsor: Iovance Biotherapeutics, Inc.
Sex: All
Age: 18 - 70
Code: NCT05361174
Phase 1, Phase 2, Recruiting
Staged Complete Revascularization for Coronary Artery Disease vs Medical Management Alone in Patients With AS Undergoing Transcatheter Aortic Valve Replacement
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
for
Peripheral T-Cell Lymphoma, Not Otherwise Specified,
Location: Miami FL, Atlanta GA, Chapel Hill NC, Baltimore MD,
Sponsor: Corvus Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06561048
Phase 3, Recruiting
The Path Study: Cognitive and Inflammation Targeted Gut-brain Interventions in Alcohol; Probiotics, Alcohol, Transcutaneous Vagus Nerve Stimulation, and HIV Study
for
Cognition, Gut Microbiome
Location: Coral Gables FL
Sponsor: University of Florida
Sex: All
Age: 35 - 70
Code: NCT05090267
Recruiting
Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS